Notice: This company has been marked as potentially delisted and may not be actively trading. Leisure Acquisition (LACQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends LACQ vs. PROC, LYEL, HURA, ACRS, GLSI, ACRV, PRQR, ZNTL, NKTX, and NBTXShould you be buying Leisure Acquisition stock or one of its competitors? The main competitors of Leisure Acquisition include Procaps Group (PROC), Lyell Immunopharma (LYEL), TuHURA Biosciences (HURA), Aclaris Therapeutics (ACRS), Greenwich LifeSciences (GLSI), Acrivon Therapeutics (ACRV), ProQR Therapeutics (PRQR), Zentalis Pharmaceuticals (ZNTL), Nkarta (NKTX), and Nanobiotix (NBTX). Leisure Acquisition vs. Procaps Group Lyell Immunopharma TuHURA Biosciences Aclaris Therapeutics Greenwich LifeSciences Acrivon Therapeutics ProQR Therapeutics Zentalis Pharmaceuticals Nkarta Nanobiotix Leisure Acquisition (NASDAQ:LACQ) and Procaps Group (NASDAQ:PROC) are both companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends, community ranking and profitability. Which has higher earnings and valuation, LACQ or PROC? Procaps Group has higher revenue and earnings than Leisure Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLeisure AcquisitionN/AN/A$4.31MN/AN/AProcaps Group$409.92MN/A$42.54MN/AN/A Which has more risk and volatility, LACQ or PROC? Leisure Acquisition has a beta of -0.3, suggesting that its stock price is 130% less volatile than the S&P 500. Comparatively, Procaps Group has a beta of -0.03, suggesting that its stock price is 103% less volatile than the S&P 500. Do institutionals & insiders hold more shares of LACQ or PROC? 56.7% of Leisure Acquisition shares are owned by institutional investors. 39.6% of Leisure Acquisition shares are owned by insiders. Comparatively, 19.9% of Procaps Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community favor LACQ or PROC? Procaps Group received 3 more outperform votes than Leisure Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformLeisure AcquisitionN/AN/AProcaps GroupOutperform Votes337.50% Underperform Votes562.50% Is LACQ or PROC more profitable? Leisure Acquisition's return on equity of 30.17% beat Procaps Group's return on equity.Company Net Margins Return on Equity Return on Assets Leisure AcquisitionN/A 30.17% 6.14% Procaps Group N/A N/A N/A Does the media favor LACQ or PROC? In the previous week, Procaps Group had 2 more articles in the media than Leisure Acquisition. MarketBeat recorded 2 mentions for Procaps Group and 0 mentions for Leisure Acquisition. Procaps Group's average media sentiment score of 1.44 beat Leisure Acquisition's score of -1.38 indicating that Procaps Group is being referred to more favorably in the news media. Company Overall Sentiment Leisure Acquisition Negative Procaps Group Positive SummaryProcaps Group beats Leisure Acquisition on 6 of the 10 factors compared between the two stocks. Get Leisure Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LACQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LACQ vs. The Competition Export to ExcelMetricLeisure AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$43.13M$6.90B$1.99B$9.11BDividend YieldN/A2.95%14.04%3.98%P/E RatioN/A10.0210.9017.56Price / SalesN/A348.169,765.5682.80Price / Cash20.0365.0921.4237.67Price / Book-36.475.292.484.73Net Income$4.31M$154.95M-$909.82M$224.51M Leisure Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LACQLeisure AcquisitionN/A$6.93-3.1%N/A+338.7%$43.13MN/A0.00N/ANegative NewsHigh Trading VolumePROCProcaps GroupN/A$1.57-4.8%N/A-62.6%$186.15M$414.10M0.005,500Short Interest ↓Gap UpLYELLyell Immunopharma2.4794 of 5 stars$0.63+3.6%$1.00+59.6%-72.4%$183.07M$63,000.00-0.79270Gap UpHURATuHURA BiosciencesN/A$4.18-4.1%$13.00+211.0%N/A$176.73MN/A0.00N/ANews CoverageACRSAclaris Therapeutics4.222 of 5 stars$2.45-2.4%$11.00+349.0%+93.4%$175.00M$31.25M-4.71100Short Interest ↑News CoverageGLSIGreenwich LifeSciences2.0161 of 5 stars$13.28+1.5%$38.00+186.1%+45.0%$174.63MN/A-16.603ACRVAcrivon Therapeutics1.8239 of 5 stars$5.56+2.0%$23.67+325.7%+44.2%$173.14MN/A-2.0658Short Interest ↑PRQRProQR Therapeutics2.2386 of 5 stars$2.11-2.3%$8.83+318.6%-4.8%$172.35M$7.05M-6.59180Short Interest ↑Positive NewsZNTLZentalis Pharmaceuticals2.8791 of 5 stars$2.40+8.1%$10.00+316.7%-85.6%$171.02MN/A-0.96160Analyst ForecastOptions VolumeNews CoverageNKTXNkarta3.0507 of 5 stars$2.42-2.8%$15.00+519.8%-76.4%$170.78MN/A-1.29140Positive NewsNBTXNanobiotix3.2214 of 5 stars$3.43-0.6%$12.00+249.9%-54.8%$161.66M$39.18M0.00100Short Interest ↓News CoveragePositive News Related Companies and Tools Related Companies PROC Alternatives LYEL Alternatives HURA Alternatives ACRS Alternatives GLSI Alternatives ACRV Alternatives PRQR Alternatives ZNTL Alternatives NKTX Alternatives NBTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LACQ) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leisure Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leisure Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LACQ Stock Alerts